Pediatric Rheumatology

unofficial impact factor 1.74

Open Access Highly Access Research

Summary of worldwide pediatric malignancies reported after exposure to etanercept

Peter McCroskery, Carol A Wallace, Daniel J Lovell, Scott Stryker, Nataliya Chernyukhin, Consuelo Blosch and Debra J Zack*

Pediatric Rheumatology 2010, 8:18 doi:10.1186/1546-0096-8-18

No comments have yet been made on this article.

Post a comment